Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29537374
Publication Date : //

A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial.


The aim of this study was to evaluate the efficacy and safety of the BioNIR stent compared with the Resolute Integrity stent for the treatment of coronary artery disease.

Authors : Paradies Valeria , Ben-Yehuda Ori , Jonas Michael , Banai Shmuel , Iñiguez Andres , Perlman Gidon Y , Kandzari David E , Stone Gregg W , Smits Pieter C ,

Related products :

Catalog number Product name Quantity
M1622 OliGlo™Cy3 FISH Kit - trial size, Utilizes a direct labeling methodology through reaction with the phosphate groups (terminal and backbone) on oligonucleotides, DNA or RNA, trial size, 1 kit
M1624 OliGlo™ Biotin FISH Kit - trial size, Utilizes a direct labeling methodology through reaction with the phosphate groups (terminal and backbone) on oligonucleotides, DNA or RNA, trial size, 1 kit
NCP-TK NanoCulture Trial Kit (Plates, Media, and Dispersal buffer) The Nanoculture Plating Kit is recommend to evalute the optimal culture condition for your cells. The trial kit enables you to compare plate Kit
M1620 OliGlo™ TAMRA FISH Kit - trial size, Utilizes a direct labeling methodology through reaction with the phosphate groups (terminal and backbone) on oligonucleotides, DNA or RNA, trial size, 1 kit
orb61232 Carfilzomib Carfilzomib was discovered and advanced to multiple Phase 1 and 2 clinical trials, including a pivotal Phase 2 clinical trial designed to seek accelerated approval, by Proteolix, Inc. For 5 mg
orb61275 OSI-027 OSI-027 is a potent, selective and orally bioavailable mTOR inhibitor currently in clinical trial. For research use only. 5 mg
BP1013f DYKDDDDK (x2) Tag Eluting Peptide 2
BP1013g DYKDDDDK (x2) Tag Eluting Peptide 2
BP1013i DYKDDDDK (x3) Tag Eluting Peptide 5 mg
BP1013e DYKDDDDK(x2 )Tag Eluting Peptide 1 mg
BP1013h DYKDDDDK (x3) Tag Eluting Peptide 1 mg
BP1013g DYKDDDDK (x2) Tag Eluting Peptide 10 mg
BP1013e DYKDDDDK(x2 )Tag Eluting Peptide 2
BP1013j DYKDDDDK (x3) Tag Eluting Peptide 2
BP1013f DYKDDDDK (x2) Tag Eluting Peptide 5 mg
BP1013d DYKDDDDK Tag Eluting Peptide 2
BP1013b DYKDDDDK Tag Eluting Peptide 2
BP1013i DYKDDDDK (x3) Tag Eluting Peptide 2
BP1013d DYKDDDDK Tag Eluting Peptide 10 mg
BP1013j DYKDDDDK (x3) Tag Eluting Peptide 10 mg
BP1013c DYKDDDDK Tag Eluting Peptide 5 mg
BP1013h DYKDDDDK (x3) Tag Eluting Peptide 2
BP1013b DYKDDDDK Tag Eluting Peptide 1 mg
BP1013c DYKDDDDK Tag Eluting Peptide 2
orb61282 PF-04691502 PF-04691502 is a potent and orally active PI3K_mTOR inhibitor, currently in clinical trial. For research use only. 5 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur